BRK-B vs GSBD
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
GSBD presents as a classic value trap, characterized by a stable Piotroski F-Score of 4/9 but severely compromised by deteriorating fundamentals. While the Graham Number of $17.12 suggests defensive undervaluation and the stock trades at a discount to book (0.76x), these are offset by a catastrophic dividend payout ratio of 135.92% and double-digit declines in both revenue (-17.10%) and earnings (-34.70%). The disconnect between the high dividend yield and the actual earnings capacity indicates a high probability of a dividend cut. Technical trends are completely bearish (0/100), confirming a lack of market confidence despite the low P/E ratio.
Compare Another Pair
Related Comparisons
BRK-B vs GSBD: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Goldman Sachs BDC, Inc. (GSBD) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.